Tahseen Mozaffar

Title(s)Clinical Professor, Neurology
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-2238
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    The Aga Khan University, Karachi, PakistanMBBS08/1989Medicine
    Barnes Hospital, St. Louis, MO06/1995Neurology
    Washington University, St. Louis, MO08/1997Neuromuscular Medicine

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes. Muscle Nerve. 2024 Apr 09. Lindborg SR, Goyal NA, Katz J, Burford M, Li J, Kaspi H, Abramov N, Boulanger B, Berry JD, Nicholson K, Mozaffar T, Miller R, Jenkins L, Baloh RH, Lewis R, Staff NP, Owegi MA, Dagher B, Blondheim-Shraga NR, Gothelf Y, Levy YS, Kern R, Aricha R, Windebank AJ, Bowser R, Brown RH, Cudkowicz ME. PMID: 38593477.
      View in: PubMed   Mentions:
    2. Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study. BMC Neurol. 2024 Mar 15; 24(1):96. Doody A, Alfano L, Diaz-Manera J, Lowes L, Mozaffar T, Mathews KD, Weihl CC, Wicklund M, Hung M, Statland J, Johnson NE, GRASP-LGMD Consortium. PMID: 38491364; PMCID: PMC10941356.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. 104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07). J Neurol. 2024 Feb 28. Schoser B, Kishnani PS, Bratkovic D, Byrne BJ, Claeys KG, Díaz-Manera J, Laforêt P, Roberts M, Toscano A, van der Ploeg AT, Castelli J, Goldman M, Holdbrook F, Sitaraman Das S, Wasfi Y, Mozaffar T, ATB200-07 Study Group. PMID: 38418563.
      View in: PubMed   Mentions:    Fields:    
    4. Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy. Ann Clin Transl Neurol. 2024 Mar; 11(3):629-640. Donkervoort S, Mohassel P, O'Leary M, Bonner DE, Hartley T, Acquaye N, Brull A, Mozaffar T, Saporta MA, Dyment DA, Sampson JB, Pajusalu S, Austin-Tse C, Hurth K, Cohen JS, McWalter K, Warman-Chardon J, Crunk A, Foley AR, Undiagnosed Diseases Network, Mammen AL, Wheeler MT, O'Donnell-Luria A, Bönnemann CG. PMID: 38311799; PMCID: PMC10963296.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02). J Neurol. 2024 Apr; 271(4):1787-1801. Byrne BJ, Schoser B, Kishnani PS, Bratkovic D, Clemens PR, Goker-Alpan O, Ming X, Roberts M, Vorgerd M, Sivakumar K, van der Ploeg AT, Goldman M, Wright J, Holdbrook F, Jain V, Benjamin ER, Johnson F, Das SS, Wasfi Y, Mozaffar T. PMID: 38057636; PMCID: PMC10973052.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    6. Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy: A GRASP-LGMD study. Res Sq. 2023 Oct 06. Doody A, Alfano L, Diaz-Manera J, Lowes L, Mozaffar T, Mathews K, Weihl CC, Wicklund M, Statland J, Johnson NE, GRASP-LGMD Consortium. PMID: 37886601; PMCID: PMC10602119.
      View in: PubMed   Mentions:
    7. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2023 10; 22(10):900-911. Machado PM, McDermott MP, Blaettler T, Sundgreen C, Amato AA, Ciafaloni E, Freimer M, Gibson SB, Jones SM, Levine TD, Lloyd TE, Mozaffar T, Shaibani AI, Wicklund M, Rosholm A, Carstensen TD, Bonefeld K, Jørgensen AN, Phonekeo K, Heim AJ, Herbelin L, Barohn RJ, Hanna MG, Dimachkie MM, Arimoclomol in IBM Investigator Team of the Neuromuscular Study Group. PMID: 37739573.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    8. Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice. Muscle Nerve. 2023 Nov; 68(5):762-766. Katyal N, Halldorsdottir K, Govindarajan R, Shieh P, Muley S, Reyes P, Leung KK, Mullen J, Milani-Nejad S, Korb M, Goyal NA, Mozaffar T, Goyal N, Habib AA, Muppidi S. PMID: 37695277.
      View in: PubMed   Mentions: 2     Fields:    
    9. Editorial: Inflammatory muscle diseases: an update. Front Neurol. 2023; 14:1259275. Tanboon J, Needham M, Mozaffar T, Stenzel W, Nishino I. PMID: 37614973; PMCID: PMC10442951.
      View in: PubMed   Mentions:
    10. Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis. Sci Adv. 2023 07 07; 9(27):eadd9984. Coulis G, Jaime D, Guerrero-Juarez C, Kastenschmidt JM, Farahat PK, Nguyen Q, Pervolarakis N, McLinden K, Thurlow L, Movahedi S, Hughes BS, Duarte J, Sorn A, Montoya E, Mozaffar I, Dragan M, Othy S, Joshi T, Hans CP, Kimonis V, MacLean AL, Nie Q, Wallace LM, Harper SQ, Mozaffar T, Hogarth MW, Bhattacharya S, Jaiswal JK, Golann DR, Su Q, Kessenbrock K, Stec M, Spencer MJ, Zamudio JR, Villalta SA. PMID: 37418531; PMCID: PMC10328414.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    11. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study. Lancet Neurol. 2023 07; 22(7):578-590. Granit V, Benatar M, Kurtoglu M, Miljkovic MD, Chahin N, Sahagian G, Feinberg MH, Slansky A, Vu T, Jewell CM, Singer MS, Kalayoglu MV, Howard JF, Mozaffar T, MG-001 Study Team. PMID: 37353278; PMCID: PMC10416207.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    12. Effects of enzyme replacement therapy on bone density in late onset Pompe disease. Mol Genet Metab. 2023 11; 140(3):107644. Avanti M, Martin A, Columbres RC, Mozaffar T, Kimonis V. PMID: 37515933.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial. JAMA Neurol. 2023 06 01; 80(6):558-567. Kishnani PS, Diaz-Manera J, Toscano A, Clemens PR, Ladha S, Berger KI, Kushlaf H, Straub V, Carvalho G, Mozaffar T, Roberts M, Attarian S, Chien YH, Choi YC, Day JW, Erdem-Ozdamar S, Illarioshkin S, Goker-Alpan O, Kostera-Pruszczyk A, van der Ploeg AT, An Haack K, Huynh-Ba O, Tammireddy S, Thibault N, Zhou T, Dimachkie MM, Schoser B, COMET Investigator Group. PMID: 37036722; PMCID: PMC10087094.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    14. Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis. bioRxiv. 2023 Apr 18. Coulis G, Jaime D, Guerrero-Juarez C, Kastenschmidt JM, Farahat PK, Nguyen Q, Pervolarakis N, McLinden K, Thurlow L, Movahedi S, Duarte J, Sorn A, Montoya E, Mozaffar I, Dragan M, Othy S, Joshi T, Hans CP, Kimonis V, MacLean AL, Nie Q, Wallace LM, Harper SQ, Mozaffar T, Hogarth MW, Bhattacharya S, Jaiswal JK, Golann DR, Su Q, Kessenbrock K, Stec M, Spencer MJ, Zamudio JR, Villalta SA. PMID: 37131694; PMCID: PMC10153153.
      View in: PubMed   Mentions:
    15. Provisional practice recommendation for the management of myopathy in VCP-associated multisystem proteinopathy. Ann Clin Transl Neurol. 2023 05; 10(5):686-695. Roy B, Peck A, Evangelista T, Pfeffer G, Wang L, Diaz-Manera J, Korb M, Wicklund MP, Milone M, Freimer M, Kushlaf H, Villar-Quiles RN, Stojkovic T, Needham M, Palmio J, Lloyd TE, Keung B, Mozaffar T, Weihl CC, Kimonis V. PMID: 37026610; PMCID: PMC10187720.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Imaging beyond muscle magnetic resonance imaging in inclusion body myositis. Clin Exp Rheumatol. 2023 Mar; 41(2):386-392. Goyal NA, Mozaffar T, Dimachkie MM. PMID: 36700664.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis. Neurology. 2023 02 14; 100(7):e671-e682. Bril V, Szczudlik A, Vaitkus A, Rozsa C, Kostera-Pruszczyk A, Hon P, Bednarik J, Tyblova M, Köhler W, Toomsoo T, Nowak RJ, Mozaffar T, Freimer ML, Nicolle MW, Magnus T, Pulley MT, Rivner M, Dimachkie MM, Distad BJ, Pascuzzi RM, Babiar D, Lin J, Querolt Coll M, Griffin R, Mondou E. PMID: 36270895; PMCID: PMC9969924.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. GNE myopathy: History, etiology, and treatment trials. Front Neurol. 2022; 13:1002310. Mullen J, Alrasheed K, Mozaffar T. PMID: 36330422; PMCID: PMC9623016.
      View in: PubMed   Mentions: 1  
    19. Inclusion body myositis: evolving concepts. Curr Opin Neurol. 2022 10 01; 35(5):604-610. Perez-Rosendahl M, Mozaffar T. PMID: 36069417; PMCID: PMC9472875.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Facial Onset Sensory and Motor Neuronopathy-Like Syndrome: A Case Report. J Clin Neuromuscul Dis. 2022 Sep 01; 24(1):55-58. Bruss DM, Venkataraman P, Mozaffar T. PMID: 36005474.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Correlations of disease severity outcome measures in inclusion body myositis. Neuromuscul Disord. 2022 10; 32(10):800-805. Goyal NA, Greenberg SA, Cauchi J, Araujo N, Li V, Wencel M, Irani T, Wang LH, Palma AM, Villalta SA, Mozaffar T. PMID: 36050251; PMCID: PMC10069380.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview. Curr Treat Options Neurol. 2022 Nov; 24(11):573-588. Stevens D, Milani-Nejad S, Mozaffar T. PMID: 36969713; PMCID: PMC10035871.
      View in: PubMed   Mentions: 5  
    23. Utility of video-fundoscopy and prospects of portable stereo-photography of the ocular fundus in neurological patients. BMC Neurol. 2022 Feb 19; 22(1):61. Khachatryan T, Mozaffar T, Mnatsakanyan L. PMID: 35183131; PMCID: PMC8857737.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    24. Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells. Neurology. 2022 03 29; 98(13):e1374-e1383. Goyal NA, Coulis G, Duarte J, Farahat PK, Mannaa AH, Cauchii J, Irani T, Araujo N, Wang L, Wencel M, Li V, Zhang L, Greenberg SA, Mozaffar T, Villalta SA. PMID: 35131904; PMCID: PMC8967422.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    25. Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy. Orphanet J Rare Dis. 2022 01 29; 17(1):23. Korb M, Peck A, Alfano LN, Berger KI, James MK, Ghoshal N, Healzer E, Henchcliffe C, Khan S, Mammen PPA, Patel S, Pfeffer G, Ralston SH, Roy B, Seeley WW, Swenson A, Mozaffar T, Weihl C, Kimonis V, VCP Standards of Care Working Group. PMID: 35093159; PMCID: PMC8800193.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    26. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Sci Transl Med. 2022 01 19; 14(628):eabi9196. Britson KA, Ling JP, Braunstein KE, Montagne JM, Kastenschmidt JM, Wilson A, Ikenaga C, Tsao W, Pinal-Fernandez I, Russell KA, Reed N, Mozaffar T, Wagner KR, Ostrow LW, Corse AM, Mammen AL, Villalta SA, Larman HB, Wong PC, Lloyd TE. PMID: 35044790; PMCID: PMC9118725.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    27. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis. Muscle Nerve. 2022 03; 65(3):291-302. Cudkowicz ME, Lindborg SR, Goyal NA, Miller RG, Burford MJ, Berry JD, Nicholson KA, Mozaffar T, Katz JS, Jenkins LJ, Baloh RH, Lewis RA, Staff NP, Owegi MA, Berry DA, Gothelf Y, Levy YS, Aricha R, Kern RZ, Windebank AJ, Brown RH. PMID: 34890069; PMCID: PMC9305113.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    28. COVID-19 infection in patients with late-onset Pompe disease. Muscle Nerve. 2022 03; 65(3):334-336. Avelar J, Wencel M, Chumakova A, Mozaffar T. PMID: 34952985; PMCID: PMC8837697.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    29. Random forest: random results or meaningful insights for patients with facioscapulohumeral muscular dystrophy? Brain. 2021 12 16; 144(11):3288-3290. Alfano LN, Mozaffar T. PMID: 34636841; PMCID: PMC8677539.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial. Lancet Neurol. 2021 12; 20(12):1012-1026. Diaz-Manera J, Kishnani PS, Kushlaf H, Ladha S, Mozaffar T, Straub V, Toscano A, van der Ploeg AT, Berger KI, Clemens PR, Chien YH, Day JW, Illarioshkin S, Roberts M, Attarian S, Borges JL, Bouhour F, Choi YC, Erdem-Ozdamar S, Goker-Alpan O, Kostera-Pruszczyk A, Haack KA, Hug C, Huynh-Ba O, Johnson J, Thibault N, Zhou T, Dimachkie MM, Schoser B, COMET Investigator Group. PMID: 34800399.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    31. Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial. Lancet Neurol. 2021 12; 20(12):1027-1037. Schoser B, Roberts M, Byrne BJ, Sitaraman S, Jiang H, Laforêt P, Toscano A, Castelli J, Díaz-Manera J, Goldman M, van der Ploeg AT, Bratkovic D, Kuchipudi S, Mozaffar T, Kishnani PS, PROPEL Study Group. PMID: 34800400.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    32. Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy. Muscle Nerve. 2022 02; 65(2):237-242. Gidaro T, Gasnier E, Annoussamy M, Vissing J, Attarian S, Mozaffar T, Iyadurai S, Wagner KR, Vissière D, Walker G, Shukla SS, Servais L. PMID: 34687225.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    33. Patient reported quality of life in limb girdle muscular dystrophy. Neuromuscul Disord. 2022 01; 32(1):57-64. Kovalchick LV, Bates K, Statland J, Weihl C, Kang PB, Lowes LP, Mozaffar T, Straub V, Wicklund M, Heatwole C, Johnson NE. PMID: 34961728; PMCID: PMC10311477.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices: The IPaNeMA Study. Neurol Genet. 2021 Dec; 7(6):e623. Wencel M, Shaibani A, Goyal NA, Dimachkie MM, Trivedi J, Johnson NE, Gutmann L, Wicklund MP, Bandyopadhay S, Genge AL, Freimer ML, Goyal N, Pestronk A, Florence J, Karam C, Ralph JW, Rasheed Z, Hays M, Hopkins S, Mozaffar T. PMID: 36299500; PMCID: PMC9595038.
      View in: PubMed   Mentions: 3  
    35. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study. Muscle Nerve. 2021 12; 64(6):662-669. Siddiqi ZA, Nowak RJ, Mozaffar T, O'Brien F, Yountz M, Patti F, REGAIN Study Group. PMID: 34590717.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    36. IgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravis. J Neurol Sci. 2021 Nov 15; 430:118074. Wolfe GI, Ward ES, de Haard H, Ulrichts P, Mozaffar T, Pasnoor M, Vidarsson G. PMID: 34563918.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    37. Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses. Ann Clin Transl Neurol. 2021 07; 8(7):1398-1407. Howard JF, Karam C, Yountz M, O'Brien FL, Mozaffar T, REGAIN Study Group. PMID: 34043280; PMCID: PMC8283175.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    38. A stromal progenitor and ILC2 niche promotes muscle eosinophilia and fibrosis-associated gene expression. Cell Rep. 2021 04 13; 35(2):108997. Kastenschmidt JM, Coulis G, Farahat PK, Pham P, Rios R, Cristal TT, Mannaa AH, Ayer RE, Yahia R, Deshpande AA, Hughes BS, Savage AK, Giesige CR, Harper SQ, Locksley RM, Mozaffar T, Villalta SA. PMID: 33852849; PMCID: PMC8127948.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    39. Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies. Ann Clin Transl Neurol. 2021 03; 8(3):571-578. Ikenaga C, Findlay AR, Goyal NA, Robinson S, Cauchi J, Hussain Y, Wang LH, Kershen JC, Beson BA, Wallendorf M, Bucelli RC, Mozaffar T, Pestronk A, Weihl CC. PMID: 33556224; PMCID: PMC7951108.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    40. Results from a 3-year Non-interventional, Observational Disease Monitoring Program in Adults with GNE Myopathy. J Neuromuscul Dis. 2021; 8(2):225-234. Lochmüller H, Behin A, Tournev I, Tarnopolsky M, Horváth R, Pogoryelova O, Shah J, Koutsoukos T, Skrinar A, Kakkis E, Bedrosian CL, Mozaffar T. PMID: 33459658; PMCID: PMC8075380.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    41. Multisystem proteinopathy: Where myopathy and motor neuron disease converge. Muscle Nerve. 2021 04; 63(4):442-454. Korb MK, Kimonis VE, Mozaffar T. PMID: 33145792.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    42. A phase 2, double-blinded, placebo-controlled trial of toll-like receptor 7/8/9 antagonist, IMO-8400, in dermatomyositis. J Am Acad Dermatol. 2021 Apr; 84(4):1160-1162. Kim YJ, Schiopu E, Dankó K, Mozaffar T, Chunduru S, Lees K, Goyal NA, Sarazin J, Fiorentino DF, Sarin KY. PMID: 32781178.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    43. Minimal manifestation status and prednisone withdrawal in the MGTX trial. Neurology. 2020 08 11; 95(6):e755-e766. Lee I, Kuo HC, Aban IB, Cutter GR, McPherson T, Kaminski HJ, Sussman J, Ströbel P, Oger J, Cea G, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJG, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Minisman G, Sonett JR, Wolfe GI, MGTX study group. PMID: 32611638; PMCID: PMC7455358.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    44. Attitudes Toward Noninterventional Observational Studies in US and Australian Patients With Sporadic Inclusion Body Myositis. J Clin Neuromuscul Dis. 2020 Jun; 21(4):246-247. Mathew V, Wencel M, Habib AA, Goyal NA, Needham M, Mozaffar T. PMID: 32453104.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Update on immune-mediated therapies for myasthenia gravis. Muscle Nerve. 2020 11; 62(5):579-592. Habib AA, Ahmadi Jazi G, Mozaffar T. PMID: 32462710.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    46. Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. JAMA Neurol. 2020 05 01; 77(5):582-592. Howard JF, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Zilucoplan MG Study Group, Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M. PMID: 32065623; PMCID: PMC7042797.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    47. Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020 05; 21(3-4):263-272. Mitsumoto H, Garofalo DC, Santella RM, Sorenson EJ, Oskarsson B, Fernandes JAM, Andrews H, Hupf J, Gilmore M, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Nations SP, Swenson AJ, Factor-Litvak P. PMID: 32276554; PMCID: PMC7373369.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    48. Examination of the human motor endplate after brachial plexus injury with two-photon microscopy. Muscle Nerve. 2020 03; 61(3):390-395. Chan JP, Clune J, Shah SB, Ward SR, Kocsis JD, Mozaffar T, Steward O, Gupta R. PMID: 31820462.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    49. Corrigendum to "Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients". Behav Neurol. 2019; 2019:6704740. Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Garofalo DC, Lomen-Hoerth C, Andrews H, Heitzman D, Bedlack R, Katz J, Barohn R, Sorenson E, Oskarsson B, Filho AF, Kasarskis E, Mozaffar T, Nations S, Swenson A, Koczon-Jaremko A, Christodoulou G, Mitsumoto H. PMID: 31885727; PMCID: PMC6914922.
      View in: PubMed   Mentions:    Fields:    
    50. Oculopharyngeal Muscular Dystrophy, an Often Misdiagnosed Neuromuscular Disorder: A Southern California Experience. J Clin Neuromuscul Dis. 2019 Dec; 21(2):61-68. Goyal NA, Mozaffar T, Chui LA. PMID: 31743248.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. QuantiMus: A Machine Learning-Based Approach for High Precision Analysis of Skeletal Muscle Morphology. Front Physiol. 2019; 10:1416. Kastenschmidt JM, Ellefsen KL, Mannaa AH, Giebel JJ, Yahia R, Ayer RE, Pham P, Rios R, Vetrone SA, Mozaffar T, Villalta SA. PMID: 31849692; PMCID: PMC6895564.
      View in: PubMed   Mentions: 11  
    52. Adult MTM1-related myopathy carriers: Classification based on deep phenotyping. Neurology. 2019 10 15; 93(16):e1535-e1542. Cocanougher BT, Flynn L, Yun P, Jain M, Waite M, Vasavada R, Wittenbach JD, de Chastonay S, Chhibber S, Innes AM, MacLaren L, Mozaffar T, Arai AE, Donkervoort S, Bönnemann CG, Foley AR. PMID: 31541013; PMCID: PMC6815204.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    53. Limb-girdle muscular dystrophy: A perspective from adult patients on what matters most. Muscle Nerve. 2019 10; 60(4):419-424. Hunter M, Heatwole C, Wicklund M, Weihl CC, Mozaffar T, Statland JM, Johnson NE. PMID: 31298728.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Reader response: Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis. Neurology. 2019 07 23; 93(4):183-184. Robbins NM, Mozaffar T, Mammen AL, Liewluck T, Guidon A, Lawson VH. PMID: 31332091.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. New family with HSPB8-associated autosomal dominant rimmed vacuolar myopathy. Neurol Genet. 2019 Aug; 5(4):e349. Al-Tahan S, Weiss L, Yu H, Tang S, Saporta M, Vihola A, Mozaffar T, Udd B, Kimonis V. PMID: 31403083; PMCID: PMC6659134.
      View in: PubMed   Mentions: 17  
    56. Variable clinical features and genotype-phenotype correlations in 18 patients with late-onset Pompe disease. Ann Transl Med. 2019 Jul; 7(13):276. Alandy-Dy J, Wencel M, Hall K, Simon J, Chen Y, Valenti E, Yang J, Bali D, Lakatos A, Goyal N, Mozaffar T, Kimonis V. PMID: 31392188; PMCID: PMC6642945.
      View in: PubMed   Mentions: 6  
    57. SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain. J Med Genet. 2019 10; 56(10):693-700. Lemmers RJLF, van der Stoep N, Vliet PJV, Moore SA, San Leon Granado D, Johnson K, Topf A, Straub V, Evangelista T, Mozaffar T, Kimonis V, Shaw ND, Selvatici R, Ferlini A, Voermans N, van Engelen B, Sacconi S, Tawil R, Lamers M, van der Maarel SM. PMID: 31243061; PMCID: PMC6800092.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    58. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis. Neurology. 2019 06 04; 92(23):e2661-e2673. Howard JF, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, Beydoun S, Garrido FJRR, Piehl F, Rottoli M, Van Damme P, Vu T, Evoli A, Freimer M, Mozaffar T, Ward ES, Dreier T, Ulrichts P, Verschueren K, Guglietta A, de Haard H, Leupin N, Verschuuren JJGM, Efgartigimod MG Study Group. PMID: 31118245; PMCID: PMC6556100.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCTClinical Trials
    59. Homozygosity for the A431E mutation in PSEN1 presenting with a relatively aggressive phenotype. Neurosci Lett. 2019 04 23; 699:195-198. Parker J, Mozaffar T, Messmore A, Deignan JL, Kimonis VE, Ringman JM. PMID: 30716424; PMCID: PMC7759143.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    60. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Lancet Neurol. 2019 03; 18(3):259-268. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR, MGTX Study Group. PMID: 30692052; PMCID: PMC6774753.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    61. A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy. Neurology. 2019 04 30; 92(18):e2109-e2117. Lochmüller H, Behin A, Caraco Y, Lau H, Mirabella M, Tournev I, Tarnopolsky M, Pogoryelova O, Woods C, Lai A, Shah J, Koutsoukos T, Skrinar A, Mansbach H, Kakkis E, Mozaffar T. PMID: 31036580; PMCID: PMC6512882.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    62. Expanding the importance of HMERF titinopathy: new mutations and clinical aspects. J Neurol. 2019 Mar; 266(3):680-690. Palmio J, Leonard-Louis S, Sacconi S, Savarese M, Penttilä S, Semmler AL, Kress W, Mozaffar T, Lai T, Stojkovic T, Berardo A, Reisin R, Attarian S, Urtizberea A, Cobo AM, Maggi L, Kurbatov S, Nikitin S, Milisenda JC, Fatehi F, Raimondi M, Silveira F, Hackman P, Claeys KG, Udd B. PMID: 30666435; PMCID: PMC6394805.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    63. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol. 2018 Dec; 5(12):1574-1587. Nallamilli BRR, Chakravorty S, Kesari A, Tanner A, Ankala A, Schneider T, da Silva C, Beadling R, Alexander JJ, Askree SH, Whitt Z, Bean L, Collins C, Khadilkar S, Gaitonde P, Dastur R, Wicklund M, Mozaffar T, Harms M, Rufibach L, Mittal P, Hegde M. PMID: 30564623; PMCID: PMC6292381.
      View in: PubMed   Mentions: 61     Fields:    
    64. Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial. Muscle Nerve. 2019 02; 59(2):201-207. Statland JM, Moore D, Wang Y, Walsh M, Mozaffar T, Elman L, Nations SP, Mitsumoto H, Fernandes JA, Saperstein D, Hayat G, Herbelin L, Karam C, Katz J, Wilkins HM, Agbas A, Swerdlow RH, Santella RM, Dimachkie MM, Barohn RJ, Rasagiline Investigators of the Muscle Study Group and Western ALS Consortium. PMID: 30192007; PMCID: PMC6545236.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    65. Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients. Behav Neurol. 2018; 2018:5969137. Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Garofalo DC, Lomen-Hoerth C, Andrews H, Heitzman D, Bedlack R, Katz J, Barohn R, Sorenson E, Oskarsson B, Filho AF, Kasarskis E, Mozaffar T, Nations S, Swenson A, Koczon-Jaremko A, Christodoulou G, Mitsumoto H. PMID: 30515252; PMCID: PMC6234441.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    66. Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. Lancet Neurol. 2018 12; 17(12):1043-1052. Grunseich C, Miller R, Swan T, Glass DJ, El Mouelhi M, Fornaro M, Petricoul O, Vostiar I, Roubenoff R, Meriggioli MN, Kokkinis A, Guber RD, Budron MS, Vissing J, Soraru G, Mozaffar T, Ludolph A, Kissel JT, Fischbeck KH, BVS857 study group. PMID: 30337273; PMCID: PMC6415539.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    67. Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy study. Neurol Clin Pract. 2018 Oct; 8(5):429-436. Levine TD, Katz JS, Barohn R, Vaughan LJ, Dimachkie MM, Saperstein DS, Mozaffar T, Wolfe GI, Mayo MS, Badger GJ, Katzin L, Ritt E, Greer M, DiStefano J, Schmidt PM. PMID: 30564497; PMCID: PMC6276327.
      View in: PubMed   Mentions: 4  
    68. Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies. Curr Treat Options Neurol. 2018 Jul 23; 20(9):37. Goyal NA, Mozaffar T. PMID: 30033499.
      View in: PubMed   Mentions:
    69. A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene. Neuromuscul Disord. 2018 09; 28(9):778-786. Plewa J, Surampalli A, Wencel M, Milad M, Donkervoort S, Caiozzo VJ, Goyal N, Mozaffar T, Kimonis V. PMID: 30097247; PMCID: PMC6490182.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial. Muscle Nerve. 2018 Mar 06. Oskarsson B, Moore D, Mozaffar T, Ravits J, Wiedau-Pazos M, Parziale N, Joyce NC, Mandeville R, Goyal N, Cudkowicz ME, Weiss M, Miller RG, McDonald CM. PMID: 29510461; PMCID: PMC6126993.
      View in: PubMed   Mentions: 19     Fields:    
    71. Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy. Clin Genet. 2018 Jan; 93(1):119-125. Al-Obeidi E, Al-Tahan S, Surampalli A, Goyal N, Wang AK, Hermann A, Omizo M, Smith C, Mozaffar T, Kimonis V. PMID: 28692196; PMCID: PMC5739971.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    72. Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α. Mol Ther. 2017 05 03; 25(5):1199-1208. Kishnani P, Tarnopolsky M, Roberts M, Sivakumar K, Dasouki M, Dimachkie MM, Finanger E, Goker-Alpan O, Guter KA, Mozaffar T, Pervaiz MA, Laforet P, Levine T, Adera M, Lazauskas R, Sitaraman S, Khanna R, Benjamin E, Feng J, Flanagan JJ, Barth J, Barlow C, Lockhart DJ, Valenzano KJ, Boudes P, Johnson FK, Byrne B. PMID: 28341561; PMCID: PMC5417791.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    73. Sporadic inclusion body myositis misdiagnosed as idiopathic granulomatous myositis. Neuromuscul Disord. 2016 11; 26(11):741-743. Lavian M, Goyal N, Mozaffar T. PMID: 27692540.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med. 2016 08 11; 375(6):511-22. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR, MGTX Study Group. PMID: 27509100; PMCID: PMC5189669.
      View in: PubMed   Mentions: 241     Fields:    Translation:Humans
    75. Critically re-evaluating a common technique: Accuracy, reliability, and confirmation bias of EMG. Neurology. 2016 08 09; 87(6):645. Charles JA, Souayah N, Narayanaswami P, Jones L, Weiss M, Mozaffar T, Rutkove SB. PMID: 27502964.
      View in: PubMed   Mentions:    Fields:    
    76. A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis. Neurology. 2016 Jul 05; 87(1):57-64. Pasnoor M, He J, Herbelin L, Burns TM, Nations S, Bril V, Wang AK, Elsheikh BH, Kissel JT, Saperstein D, Shaibani JA, Jackson C, Swenson A, Howard JF, Goyal N, David W, Wicklund M, Pulley M, Becker M, Mozaffar T, Benatar M, Pazcuzzi R, Simpson E, Rosenfeld J, Dimachkie MM, Statland JM, Barohn RJ, Methotrexate in MG Investigators of the Muscle Study Group. PMID: 27306628; PMCID: PMC4932232.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    77. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. J Neurol Neurosurg Psychiatry. 2017 Feb; 88(2):99-105. Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, Ratti E, Atassi N, Boylan KB, Glass JD, Maragakis NJ, Caress JB, McCluskey LF, Appel SH, Wymer JP, Gibson S, Zinman L, Mozaffar T, Callaghan B, McVey AL, Jockel-Balsarotti J, Allred P, Fisher ER, Lopate G, Pestronk A, Cudkowicz ME, Miller TM. PMID: 27261500; PMCID: PMC5136332.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    78. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study. Mol Genet Metab. 2016 09; 119(1-2):115-23. van der Ploeg A, Carlier PG, Carlier RY, Kissel JT, Schoser B, Wenninger S, Pestronk A, Barohn RJ, Dimachkie MM, Goker-Alpan O, Mozaffar T, Pena LD, Simmons Z, Straub V, Guglieri M, Young P, Boentert M, Baudin PY, Wens S, Shafi R, Bjartmar C, Thurberg BL. PMID: 27473031.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    79. Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA. J Neuromuscul Dis. 2016 03 03; 3(1):67-75. Price MA, Barghout V, Benveniste O, Christopher-Stine L, Corbett A, de Visser M, Hilton-Jones D, Kissel JT, Lloyd TE, Lundberg IE, Mastaglia F, Mozaffar T, Needham M, Schmidt J, Sivakumar K, DeMuro C, Tseng BS. PMID: 27854208; PMCID: PMC5271419.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    80. Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology. 2016 Mar 01; 86(9):813-20. Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, Singleton J, Woolley S, Andrews H, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Koczon-Jaremko BA, Mitsumoto H, ALS COSMOS. PMID: 26802094; PMCID: PMC4793785.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    81. Critically re-evaluating a common technique: Accuracy, reliability, and confirmation bias of EMG. Neurology. 2016 Jan 19; 86(3):218-23. Narayanaswami P, Geisbush T, Jones L, Weiss M, Mozaffar T, Gronseth G, Rutkove SB. PMID: 26701380; PMCID: PMC4733154.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    82. Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine. Muscle Nerve. 2016 Feb; 53(2):165-8. Burns TM, Smith GA, Allen JA, Amato AA, Arnold WD, Barohn R, Benatar M, Bird SJ, Bromberg M, Chahin N, Ciafaloni E, Cohen JA, Corse A, Crum BA, David WS, Dimberg E, Sousa EA, Donofrio PD, Dyck PJ, Engel AG, Ensrud ER, Ferrante M, Freimer M, Gable KL, Gibson S, Gilchrist JM, Goldstein JM, Gooch CL, Goodman BP, Gorelov D, Gospe SM, Goyal NA, Guidon AC, Guptill JT, Gutmann L, Gutmann L, Gwathmey K, Harati Y, Harper CM, Hehir MK, Hobson-Webb LD, Howard JF, Jackson CE, Johnson N, Jones SM, Juel VC, Kaminski HJ, Karam C, Kennelly KD, Khella S, Khoury J, Kincaid JC, Kissel JT, Kolb N, Lacomis D, Ladha S, Larriviere D, Lewis RA, Li Y, Litchy WJ, Logigian E, Lou JS, MacGowen DJ, Maselli R, Massey JM, Mauermann ML, Mathews KD, Meriggioli MN, Miller RG, Moon JS, Mozaffar T, Nations SP, Nowak RJ, Ostrow LW, Pascuzzi RM, Peltier A, Ruzhansky K, Richman DP, Ross MA, Rubin DI, Russell JA, Sachs GM, Salajegheh MK, Saperstein DS, Scelsa S, Selcen D, Shaibani A, Shieh PB, Silvestri NJ, Singleton JR, Smith BE, So YT, Solorzano G, Sorenson EJ, Srinivasen J, Tavee J, Tawil R, Thaisetthawatkul P, Thornton C, Trivedi J, Vernino S, Wang AK, Webb TA, Weiss MD, Windebank AJ, Wolfe GI. PMID: 26662952.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late-onset Pompe disease. Neuromuscul Disord. 2016 Feb; 26(2):136-45. Johnson EM, Roberts M, Mozaffar T, Young P, Quartel A, Berger KI. PMID: 26794303.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    84. GMPPB-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation. Hum Mutat. 2015 Dec; 36(12):1159-63. Jensen BS, Willer T, Saade DN, Cox MO, Mozaffar T, Scavina M, Stefans VA, Winder TL, Campbell KP, Moore SA, Mathews KD. PMID: 26310427; PMCID: PMC4843780.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    85. Tongue atrophy and fasciculations in transthyretin familial amyloid neuropathy: An ALS mimicker. Neurol Genet. 2015 Aug; 1(2):e18. Goyal NA, Mozaffar T. PMID: 27066555; PMCID: PMC4807904.
      View in: PubMed   Mentions: 6  
    86. Diagnostic value of MRI in inflammatory myositis. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e128. Lai TT, Mozaffar T. PMID: 26185775; PMCID: PMC4503409.
      View in: PubMed   Mentions:    Fields:    
    87. Desert hedgehog is a mediator of demyelination in compression neuropathies. Exp Neurol. 2015 Sep; 271:84-94. Jung J, Frump D, Su J, Wang W, Mozaffar T, Gupta R. PMID: 25936873.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    88. An overview of polymyositis and dermatomyositis. Muscle Nerve. 2015 May; 51(5):638-56. Findlay AR, Goyal NA, Mozaffar T. PMID: 25641317.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    89. Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement. J Neurol Neurosurg Psychiatry. 2016 Apr; 87(4):373-8. Goyal NA, Cash TM, Alam U, Enam S, Tierney P, Araujo N, Mozaffar FH, Pestronk A, Mozaffar T. PMID: 25857661; PMCID: PMC6192256.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    90. Activation of the Wnt/β-catenin signaling cascade after traumatic nerve injury. Neuroscience. 2015 May 21; 294:101-8. Kurimoto S, Jung J, Tapadia M, Lengfeld J, Agalliu D, Waterman M, Mozaffar T, Gupta R. PMID: 25743255; PMCID: PMC5384639.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    91. Topical tranexamic Acid does not affect electrophysiologic or neurovascular sciatic nerve markers in an animal model. Clin Orthop Relat Res. 2015 Mar; 473(3):1074-82. Schwarzkopf R, Dang P, Luu M, Mozaffar T, Gupta R. PMID: 25560955; PMCID: PMC4317440.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    92. A Phase 4 Prospective Study in Patients with Adult Pompe Disease Treated with Alglucosidase Alfa. J Neuromuscul Dis. 2015; 2(s1):S72-S73. Thurberg BL, Carlier P, Kissel JT, Schoser B, Pestronk A, Barohn RJ, Goker-Alpan O, Mozaffar T, Pena LD, Simmons Z, Straub V, Young P, Shafi R, Bjartmar C, van der Ploeg A. PMID: 27858658.
      View in: PubMed   Mentions: 1     Fields:    
    93. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs. Expert Opin Investig Drugs. 2014 Nov; 23(11):1541-51. Goyal NA, Mozaffar T. PMID: 24965719.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    94. Early Surgical Decompression Restores Neurovascular Blood Flow and Ischemic Parameters in an in Vivo Animal Model of Nerve Compression Injury. J Bone Joint Surg Am. 2014 Jun 04; 96(11):897-906. Jung J, Hahn P, Choi B, Mozaffar T, Gupta R. PMID: 24897737; PMCID: PMC4049242.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    95. Patient characteristics and comorbidities associated with cerebrovascular accident following acute myocardial infarction in the United States. Int J Cardiol. 2014 Aug 01; 175(2):323-7. Naderi N, Masoomi H, Mozaffar T, Malik S. PMID: 24874908; PMCID: PMC4121439.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    96. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014 Jun 14; 383(9934):2065-2072. Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, Brooks B, Gelinas D, Mitsumoto H, Mozaffar T, Hanes GP, Ladha SS, Heiman-Patterson T, Katz J, Lou JS, Mahoney K, Grasso D, Lawson R, Yu H, Cudkowicz M, MDA Clinical Research Network. PMID: 24582471; PMCID: PMC4176708.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCTClinical Trials
    97. ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun; 15(3-4):192-203. Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, McElhiney M, Nieves J, Santella RM, Murphy J, Hupf J, Singleton J, Merle D, Kilty M, Heitzman D, Bedlack RS, Miller RG, Katz JS, Forshew D, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Shefner JM, Andrews JA, Koczon-Jaremko BA, ALS COSMOS Study Group. PMID: 24564738; PMCID: PMC4310702.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    98. Respiratory and nutritional support in amyotrophic lateral sclerosis. Curr Treat Options Neurol. 2014 Feb; 16(2):270. Goyal NA, Mozaffar T. PMID: 24390801.
      View in: PubMed   Mentions: 3  
    99. Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease. Hum Mol Genet. 2014 Mar 01; 23(5):1333-44. Llewellyn KJ, Nalbandian A, Jung KM, Nguyen C, Avanesian A, Mozaffar T, Piomelli D, Kimonis VE. PMID: 24158850; PMCID: PMC3919004.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    100. ALS Untangled No. 20: the Deanna protocol. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May; 14(4):319-23. ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E. PMID: 23638638.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    101. A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis. Muscle Nerve. 2013 Jul; 48(1):76-84. Howard JF, Barohn RJ, Cutter GR, Freimer M, Juel VC, Mozaffar T, Mellion ML, Benatar MG, Farrugia ME, Wang JJ, Malhotra SS, Kissel JT, MG Study Group. PMID: 23512355.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCTClinical Trials
    102. The effects of adjuvant fibrin sealant on the surgical repair of segmental nerve defects in an animal model. J Hand Surg Am. 2013 May; 38(5):847-55. Rafijah G, Bowen AJ, Dolores C, Vitali R, Mozaffar T, Gupta R. PMID: 23561728.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    103. Novel GNE mutations in autosomal recessive hereditary inclusion body myopathy patients. Genet Test Mol Biomarkers. 2013 May; 17(5):376-82. No D, Valles-Ayoub Y, Carbajo R, Khokher Z, Sandoval L, Stein B, Tarnopolsky MA, Mozaffar T, Darvish B, Pietruszka M, Darvish D. PMID: 23437777.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    104. A Review of Spasticity Treatments: Pharmacological and Interventional Approaches. Crit Rev Phys Rehabil Med. 2013; 25(1-2):11-22. Chang E, Ghosh N, Yanni D, Lee S, Alexandru D, Mozaffar T. PMID: 25750484; PMCID: PMC4349402.
      View in: PubMed   Mentions: 49  
    105. Matrix metalloproteinase 3 deletion preserves denervated motor endplates after traumatic nerve injury. Ann Neurol. 2013 Feb; 73(2):210-23. Chao T, Frump D, Lin M, Caiozzo VJ, Mozaffar T, Steward O, Gupta R. PMID: 23281061.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    106. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse. Muscle Nerve. 2013 Feb; 47(2):260-70. Nalbandian A, Llewellyn KJ, Badadani M, Yin HZ, Nguyen C, Katheria V, Watts G, Mukherjee J, Vesa J, Caiozzo V, Mozaffar T, Weiss JH, Kimonis VE. PMID: 23169451; PMCID: PMC3556223.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCells
    107. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia. Clin Genet. 2013 May; 83(5):422-31. Mehta SG, Khare M, Ramani R, Watts GD, Simon M, Osann KE, Donkervoort S, Dec E, Nalbandian A, Platt J, Pasquali M, Wang A, Mozaffar T, Smith CD, Kimonis VE. PMID: 22909335; PMCID: PMC3618576.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    108. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology. PLoS One. 2012; 7(9):e46308. Nalbandian A, Llewellyn KJ, Kitazawa M, Yin HZ, Badadani M, Khanlou N, Edwards R, Nguyen C, Mukherjee J, Mozaffar T, Watts G, Weiss J, Kimonis VE. PMID: 23029473; PMCID: PMC3460820.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    109. Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice. Cell Death Dis. 2012 Aug 16; 3:e374. Yin HZ, Nalbandian A, Hsu CI, Li S, Llewellyn KJ, Mozaffar T, Kimonis VE, Weiss JH. PMID: 22898872; PMCID: PMC3434652.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    110. Biophysical stimulation induces demyelination via an integrin-dependent mechanism. Ann Neurol. 2012 Jul; 72(1):112-23. Lin MY, Frieboes LS, Forootan M, Palispis WA, Mozaffar T, Jafari M, Steward O, Gall CM, Gupta R. PMID: 22829273.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    111. Chronic nerve compression alters Schwann cell myelin architecture in a murine model. Muscle Nerve. 2012 Feb; 45(2):231-41. Gupta R, Nassiri N, Hazel A, Bathen M, Mozaffar T. PMID: 22246880; PMCID: PMC3262776.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    112. Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology. 2011 Sep 06; 77(10):973-9. Miller RG, Moore DH, Forshew DA, Katz JS, Barohn RJ, Valan M, Bromberg MB, Goslin KL, Graves MC, McCluskey LF, McVey AL, Mozaffar T, Florence JM, Pestronk A, Ross M, Simpson EP, Appel SH, WALS Study Group. PMID: 21813790; PMCID: PMC3171956.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    113. Valosin-containing protein mutation and Parkinson's disease. Parkinsonism Relat Disord. 2012 Jan; 18(1):107-9. Chan N, Le C, Shieh P, Mozaffar T, Khare M, Bronstein J, Kimonis V. PMID: 21816654.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    114. Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29. J Neuropathol Exp Neurol. 2011 Jan; 70(1):96-7; author reply 98-100. Bedlack RS, Genge A, Amato AA, Shaibani A, Jackson CE, Kissel JT, Wall C, King WM, Cupler E, Lou JS, Ensrud E, Tan E, Goldstein JM, Katz J, Dimachkie MM, Barohn RJ, Mozaffar T. PMID: 21173608.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    115. Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE. Clin Genet. 2011 Nov; 80(5):444-51. Maselli RA, Arredondo J, Cagney O, Mozaffar T, Skinner S, Yousif S, Davis RR, Gregg JP, Sivak M, Konia TH, Thomas K, Wollmann RL. PMID: 21175599.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    116. Compressive neuropathies of the upper extremity: update on pathophysiology, classification, and electrodiagnostic findings. J Hand Surg Am. 2010 Apr; 35(4):668-77. Tapadia M, Mozaffar T, Gupta R. PMID: 20223605; PMCID: PMC4715364.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    117. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience. Muscle Nerve. 2010 Mar; 41(3):370-4. Pasnoor M, Wolfe GI, Nations S, Trivedi J, Barohn RJ, Herbelin L, McVey A, Dimachkie M, Kissel J, Walsh R, Amato A, Mozaffar T, Hungs M, Chui L, Goldstein J, Novella S, Burns T, Phillips L, Claussen G, Young A, Bertorini T, Oh S. PMID: 19882635.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    118. Neuromuscular junction integrity after chronic nerve compression injury. J Orthop Res. 2009 Jan; 27(1):114-9. Mozaffar T, Strandberg E, Abe K, Hilgenberg LG, Smith MA, Gupta R. PMID: 18655131; PMCID: PMC2670070.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    119. A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Scler. 2008 Aug; 9(4):212-22. Gordon PH, Cheung YK, Levin B, Andrews H, Doorish C, Macarthur RB, Montes J, Bednarz K, Florence J, Rowin J, Boylan K, Mozaffar T, Tandan R, Mitsumoto H, Kelvin EA, Chapin J, Bedlack R, Rivner M, McCluskey LF, Pestronk A, Graves M, Sorenson EJ, Barohn RJ, Belsh JM, Lou JS, Levine T, Saperstein D, Miller RG, Scelsa SN, Combination Drug Selection Trial Study Group. PMID: 18608093; PMCID: PMC4354803.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    120. Myopathy associated with chronic orlistat consumption: a case report. Neuromuscul Disord. 2008 May; 18(5):410-2. Ringman JM, Mozaffar T. PMID: 18430571.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    121. The spectrum of neurological complications in Pakistani patients with malignancies. J Pak Med Assoc. 2008 Apr; 58(4):160-4. Sharfuddin AA, Fatima H, Jilani SM, Mozaffar FH, Mozaffar T. PMID: 18655420.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    122. Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using surveyor strategy. Mitochondrion. 2008 Mar; 8(2):136-45. Bannwarth S, Procaccio V, Rouzier C, Fragaki K, Poole J, Chabrol B, Desnuelle C, Pouget J, Azulay JP, Attarian S, Pellissier JF, Gargus JJ, Abdenur JE, Mozaffar T, Calvas P, Labauge P, Pages M, Wallace DC, Lambert JC, Paquis-Flucklinger V. PMID: 18078792.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    123. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007 Dec; 6(12):1045-53. Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H, Neville HE, Boylan K, Mozaffar T, Belsh JM, Ravits J, Bedlack RS, Graves MC, McCluskey LF, Barohn RJ, Tandan R, Western ALS Study Group. PMID: 17980667.
      View in: PubMed   Mentions: 245     Fields:    Translation:HumansCTClinical Trials
    124. The role of neurodiagnostic studies in nerve injuries and other orthopedic disorders. J Hand Surg Am. 2007 Oct; 32(8):1280-90. Strandberg EJ, Mozaffar T, Gupta R. PMID: 17923316.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    125. N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration. J Biol Chem. 2007 Nov 16; 282(46):33725-33734. Lee SU, Grigorian A, Pawling J, Chen IJ, Gao G, Mozaffar T, McKerlie C, Demetriou M. PMID: 17855338.
      View in: PubMed   Mentions: 61     Fields:    Translation:AnimalsCells
    126. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med. 2007 Aug 23; 357(8):775-88. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, Halperin RF, Stamper C, Jensen KR, Letizia D, Hesterlee SE, Pestronk A, Levine T, Bertorini T, Graves MC, Mozaffar T, Jackson CE, Bosch P, McVey A, Dick A, Barohn R, Lomen-Hoerth C, Rosenfeld J, O'connor DT, Zhang K, Crook R, Ryberg H, Hutton M, Katz J, Simpson EP, Mitsumoto H, Bowser R, Miller RG, Appel SH, Stephan DA. PMID: 17671248.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    127. Molecular and cellular defects of skeletal muscle in an animal model of acute quadriplegic myopathy. Muscle Nerve. 2007 Jan; 35(1):55-65. Mozaffar T, Haddad F, Zeng M, Zhang LY, Adams GR, Baldwin KM. PMID: 16967495.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    128. Minocycline-induced skin and dental pigmentations. Neurology. 2006 Dec 26; 67(12):2185. Mozaffar T, Gordon PH. PMID: 17190941.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    129. Local down-regulation of myelin-associated glycoprotein permits axonal sprouting with chronic nerve compression injury. Exp Neurol. 2006 Aug; 200(2):418-29. Gupta R, Rummler LS, Palispis W, Truong L, Chao T, Rowshan K, Mozaffar T, Steward O. PMID: 16764860.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    130. Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer. Anticancer Drugs. 2006 Jan; 17(1):103-5. Choi J, Kong K, Mozaffar T, Holcombe RF. PMID: 16317297.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    131. Schwann cells upregulate vascular endothelial growth factor secondary to chronic nerve compression injury. Muscle Nerve. 2005 Apr; 31(4):452-60. Gupta R, Gray M, Chao T, Bear D, Modafferi E, Mozaffar T. PMID: 15685607.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    132. Chronic nerve compression induces local demyelination and remyelination in a rat model of carpal tunnel syndrome. Exp Neurol. 2004 Jun; 187(2):500-8. Gupta R, Rowshan K, Chao T, Mozaffar T, Steward O. PMID: 15144876.
      View in: PubMed   Mentions: 44     Fields:    Translation:AnimalsCells
    133. Ischemic stroke subtypes in Pakistan: the Aga Khan University Stroke Data Bank. J Pak Med Assoc. 2003 Dec; 53(12):584-8. Syed NA, Khealani BA, Ali S, Hasan A, Akhtar N, Brohi H, Mozaffar T, Ahmed N, Hameed A, Baig SM, Wasay M. PMID: 14765937.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    134. Critical care myopathy: an emerging medical catastrophe. J Pak Med Assoc. 2003 Dec; 53(12):608-11. Mozaffar T, Mozaffar FH. PMID: 14765943.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    135. Macrophage recruitment follows the pattern of inducible nitric oxide synthase expression in a model for carpal tunnel syndrome. J Neurotrauma. 2003 Jul; 20(7):671-80. Gupta R, Lin YM, Bui P, Chao T, Preston C, Mozaffar T. PMID: 12908928.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    136. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology. 2003 Jun 10; 60(11):1811-6. Donaldson MR, Jensen JL, Tristani-Firouzi M, Tawil R, Bendahhou S, Suarez WA, Cobo AM, Poza JJ, Behr E, Wagstaff J, Szepetowski P, Pereira S, Mozaffar T, Escolar DM, Fu YH, Ptácek LJ. PMID: 12796536.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    137. The neuropathology of leprosy. Arch Neurol. 2002 Jan; 59(1):138-40. Habib AA, Mozaffar T. PMID: 11790242.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    138. Critical illness myopathy. Muscle Nerve. 2001 Jul; 24(7):973-4. Mozaffar T. PMID: 11410928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    139. Cerebral artery air embolism following an esophagogastroscopy: a case report. Neurology. 2001 Jan 09; 56(1):136-7. Akhtar N, Jafri W, Mozaffar T. PMID: 11148258.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    140. Gram negative meningitis resulting from rupture of a spinal epidural abscess into the subarachnoid space. J Pak Med Assoc. 2000 Nov; 50(11):393-4. Lodhi S, Mozaffar T, Sarwari AR. PMID: 11126818.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    141. Factor XI deficiency-related spontaneous primary intraventricular hemorrhage. South Med J. 2000 Oct; 93(10):1017-8. Khealani B, Farhat Z, Mozaffar T. PMID: 11147466.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    142. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatry. 2000 Apr; 68(4):472-8. Mozaffar T, Pestronk A. PMID: 10727483; PMCID: PMC1736872.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    143. Chronic subdural haematoma presenting with transient ischaemic attacks--a case report. Ann Acad Med Singap. 1999 Nov; 28(6):861-2. Khealani B, Mozaffar T. PMID: 10672404.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    144. Dysphagia in hereditary sensory autonomic neuropathy type IV. J Pak Med Assoc. 1999 May; 49(5):121-3. Shah U, Arshad M, Mozaffar T. PMID: 10555429.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    145. Neuralgic amyotrophy (Parsonage-Turner syndrome): an often misdiagnosed diagnosis. J Pak Med Assoc. 1999 Apr; 49(4):101-3. Saleem F, Mozaffar T. PMID: 10540541.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    146. Clinical correlates of granulomas in muscle. J Neurol. 1998 Aug; 245(8):519-24. Mozaffar T, Lopate G, Pestronk A. PMID: 9747915.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    147. Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology. 1998 Mar; 50(3):764-7. Levin MI, Mozaffar T, Al-Lozi MT, Pestronk A. PMID: 9521271.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    148. Case 21-1997: Paraneoplastic cerebellar degeneration and Hodgkin's disease. N Engl J Med. 1998 Jan 01; 338(1):66. Mozaffar T. PMID: 9424575.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Tahseen's Networks
    Concepts (529)
    Derived automatically from this person's publications.
    _
    Co-Authors (54)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _